NOP56 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.271000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.200800E-01
Normal-vs-Stage2
6.369000E-01
Normal-vs-Stage3
5.072800E-01
Normal-vs-Stage4
6.251600E-01
Stage1-vs-Stage2
1.349210E-01
Stage1-vs-Stage3
2.535400E-01
Stage1-vs-Stage4
3.530200E-01
Stage2-vs-Stage3
3.526200E-01
Stage2-vs-Stage4
8.558600E-01
Stage3-vs-Stage4
6.340600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.031200E-01
Normal-vs-AfricanAmerican
5.270600E-01
Normal-vs-Asian
1.941550E-01
Caucasian-vs-AfricanAmerican
5.892400E-01
Caucasian-vs-Asian
1.019600E-01
AfricanAmerican-vs-Asian
3.373200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.694600E-01
Normal-vs-Female
6.951400E-01
Male-vs-Female
7.492400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.951600E-01
Normal-vs-Age(41-60Yrs)
8.092800E-01
Normal-vs-Age(61-80Yrs)
6.625200E-01
Normal-vs-Age(81-100Yrs)
9.217000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.987400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.288000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.683000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.306400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.991200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.887000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.043600E-01
Normal-vs-Daily Drinker
4.612000E-01
Normal-vs-Weekly Drinker
8.514200E-01
Normal-vs-Occasional Drinker
9.968600E-01
Normal-vs-Social Drinker
7.265800E-01
Non Drinker-vs-Daily Drinker
9.028600E-01
Non Drinker-vs-Weekly Drinker
2.101600E-01
Non Drinker-vs-Occasional Drinker
1.576570E-01
Non Drinker-vs-Social Drinker
3.833400E-01
Daily Drinker-vs-Weekly Drinker
2.287000E-01
Daily Drinker-vs-Occasional Drinker
1.603600E-01
Daily Drinker-vs-Social Drinker
3.783600E-01
Weekly Drinker-vs-Occasional Drinker
7.029200E-01
Weekly Drinker-vs-Social Drinker
4.527200E-01
Occasional Drinker-vs-Social Drinker
5.571600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.768200E-01
Normal-vs-Grade 2
7.449000E-01
Normal-vs-Grade 3
7.579800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.838000E-01
Grade 1-vs-Grade 3
6.568400E-01
Grade 1-vs-Grade 4
7.768200E-01
Grade 2-vs-Grade 3
6.426600E-01
Grade 2-vs-Grade 4
7.449000E-01
Grade 3-vs-Grade 4
7.579800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.782600E-01
Normal-vs-NonDiabetic
7.956400E-01
Diabetic-vs-NonDiabetic
2.051200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.168810E-01
Normal-vs-NoPancreatitis
7.784200E-01
Pancreatitis-vs-NoPancreatitis
5.077800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.984400E-01
Normal-vs-N1
6.639200E-01
N0-vs-N1
3.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.580000E-01
Normal-vs-TP53-NonMutant
9.189800E-01
TP53-Mutant-vs-TP53-NonMutant
8.927800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
